Cubic Corp. (CUB) Jumps 7.82% on February 16

Equities Staff |

Cubic Corp. (CUB) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 7.82% to $34.06, representing a gain of $2.47 per share. Some 247,799 shares traded hands on 1,913 trades, compared with an average daily volume of 165,035 shares out of a total float of 26.97 million. The stock opened at $32.30 and traded with an intraday range of $34.28 to $31.91.

After today's gains, Cubic Corp. reached a market cap of $918.68 million. Cubic Corp. has had a trading range between $54.31 and $30.11 over the last year, and it had a 50-day SMA of $42.93 and a 200-day SMA of $44.55.

The stock has a P/E Ratio of 68.7.

Cubic Corp is engaged in the design, development, manufacture, integration, and sustainment of technology systems and products. It also provides engineering, training, technical, logistic, and information technology services.

Cubic Corp. is based out of San Diego, CA and has some 8,300 employees. Its CEO is Bradley H. Feldmann.

For a complete fundamental analysis analysis of Cubic Corp., check out’s Stock Valuation Analysis report for CUB. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…